| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Petros Pharmaceuticals Inc (NASDAQ: PTPI)
PTPI Technical Analysis
5
| As on 11th Mar 2025 PTPI STOCK Price closed @ 0.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.06 & Strong Sell for SHORT-TERM with Stoploss of 1.48 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PTPISTOCK Price
| Open | 0.10 | Change | Price | % |
| High | 0.11 | 1 Day | 0.01 | 11.11 |
| Low | 0.09 | 1 Week | 0.00 | 0.00 |
| Close | 0.10 | 1 Month | -0.19 | -65.52 |
| Volume | 32166116 | 1 Year | -1.48 | -93.67 |
| 52 Week High 1.95 | 52 Week Low 0.08 | ||||
NASDAQ USA Most Active Stocks
| SYRS | 0.14 | 55.56% |
| AMRS | 0.14 | 100.00% |
| BHAT | 0.04 | 33.33% |
| NVDA | 108.76 | 1.66% |
| CUTR | 0.11 | -15.38% |
| AWH | 0.18 | -10.00% |
| TSLA | 230.58 | 3.79% |
| LMDX | 0.02 | 0.00% |
| LCID | 2.09 | 0.48% |
| AAL | 11.46 | -8.32% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PTPI Daily Charts |
PTPI Intraday Charts |
Whats New @ Bazaartrend |
PTPI Free Analysis |
|
|
PTPI Important Levels Intraday
| RESISTANCE | 0.14 |
| RESISTANCE | 0.13 |
| RESISTANCE | 0.12 |
| RESISTANCE | 0.11 |
| SUPPORT | 0.09 |
| SUPPORT | 0.08 |
| SUPPORT | 0.07 |
| SUPPORT | 0.06 |
PTPI Forecast March 2025
| 4th UP Forecast | 1.56 |
| 3rd UP Forecast | 1.09 |
| 2nd UP Forecast | 0.8 |
| 1st UP Forecast | 0.51 |
| 1st DOWN Forecast | -0.31 |
| 2nd DOWN Forecast | -0.6 |
| 3rd DOWN Forecast | -0.89 |
| 4th DOWN Forecast | -1.36 |
PTPI Weekly Forecast
| 4th UP Forecast | 0.89 |
| 3rd UP Forecast | 0.64 |
| 2nd UP Forecast | 0.48 |
| 1st UP Forecast | 0.32 |
| 1st DOWN Forecast | -0.12 |
| 2nd DOWN Forecast | -0.28 |
| 3rd DOWN Forecast | -0.44 |
| 4th DOWN Forecast | -0.69 |
PTPI Forecast2025
| 4th UP Forecast | 4.47 |
| 3rd UP Forecast | 3.07 |
| 2nd UP Forecast | 2.2 |
| 1st UP Forecast | 1.34 |
| 1st DOWN Forecast | -1.14 |
| 2nd DOWN Forecast | -2 |
| 3rd DOWN Forecast | -2.87 |
| 4th DOWN Forecast | -4.27 |
Petros Pharmaceuticals Inc ( NASDAQ USA Symbol : PTPI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PTPI Business Profile
Petros Pharmaceuticals, Inc. engages in identifying, acquiring, developing, and commercializing therapeutics for men's health issues in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company develops H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. It also offers prescription medication, such as Stendra for the treatment of male erectile dysfunction; and vacuum erection devices. Petros Pharmaceuticals, Inc. is based in New York, New York. Address: 1185 Avenue of the Americas, New York, NY, United States, 10036
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service